<code id='EF4105C972'></code><style id='EF4105C972'></style>
    • <acronym id='EF4105C972'></acronym>
      <center id='EF4105C972'><center id='EF4105C972'><tfoot id='EF4105C972'></tfoot></center><abbr id='EF4105C972'><dir id='EF4105C972'><tfoot id='EF4105C972'></tfoot><noframes id='EF4105C972'>

    • <optgroup id='EF4105C972'><strike id='EF4105C972'><sup id='EF4105C972'></sup></strike><code id='EF4105C972'></code></optgroup>
        1. <b id='EF4105C972'><label id='EF4105C972'><select id='EF4105C972'><dt id='EF4105C972'><span id='EF4105C972'></span></dt></select></label></b><u id='EF4105C972'></u>
          <i id='EF4105C972'><strike id='EF4105C972'><tt id='EF4105C972'><pre id='EF4105C972'></pre></tt></strike></i>

          
          WSS
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          knowledge